Regent LaPorte;Claudio Schteingart;Pierre Riviere;Kazimierz Wisniewski;Robert Felix Galyean
发明人:
Kazimierz Wisniewski,Claudio Schteingart,Regent LaPorte,Robert Felix Galyean,Pierre Riviere
申请号：
US13409976
公开号：
US20120196808A1
申请日:
2012.03.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
